Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

HEB’s insiders are looting the company:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 494
Posts 82,509
Boards Moderated 24
Alias Born 09/05/02
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
AT&T Boosts Dividend
Mobile's Rise Poses a Riddle for Banks
U.S. Hot Stocks: Hot Stocks to Watch
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
Oracle Beats Street View for First Time in a Year
Liberty Media's CommerceHub Acquires E-Commerce Adviser Mercent
DewDiligence Member Level  Tuesday, 06/02/09 06:08:42 PM
Re: exwannabe post# 78906
Post # of 184877 
HEB’s insiders are looting the company:

While pumpers are mindlessly pumping HEB on various message boards, officers and directors have been engaged in a game of their own: systematically looting the company to the greatest extent possible. Last week, without even waiting for FDA action on the Ampligen BLA, HEB paid the CEO a $300K bonus and the CMO a $150K bonus (#msg-38179694).

The BoD had the audacity to grant these bonuses despite the fact that HEB cut the salaries of its non-executive employees in Jan 2009. Despite the fact that the CEO received more than $1M in compensation in 2008. Despite the fact that the CEO received almost $3M in compensation in 2007.

Want more? HEB pays each non-employee director $150K per annum merely to attend board meetings! You can find these and other details in the recent DEF14A filing: http://sec.gov/Archives/edgar/data/946644/000114420409029059/v150612_def14a.htm .

I shudder to think how much insiders will pay themselves if by some miracle the FDA actually approves Ampligen.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist